https://aragen.targetedgestaging.in/casestudy/redefine-in-silico-predictions-with-high-throughput-lc-ms-ms-logd-analysis/ 2024-08-08T12:27:38+00:00 https://aragen.targetedgestaging.in/wp-content/uploads/2024/08/1.jpg https://aragen.targetedgestaging.in/casestudy/exploring-protac-permeability-comparative-insights-across-different-cell-lines/ 2025-06-16T12:18:45+00:00 https://aragen.targetedgestaging.in/wp-content/uploads/2025/05/1.jpg https://aragen.targetedgestaging.in/casestudy/reporter-cell-lines-for-immuno-oncology-drug-discovery-targeting-t-cell-activation/ 2025-06-16T12:19:19+00:00 https://aragen.targetedgestaging.in/wp-content/uploads/2025/05/reporter_cs_banner.jpg https://aragen.targetedgestaging.in/casestudy/leveraging-surface-plasmon-resonance-for-characterizing-ternary-complexes/ 2025-06-16T12:30:58+00:00 https://aragen.targetedgestaging.in/wp-content/uploads/2025/04/leverage_banner.jpg https://aragen.targetedgestaging.in/casestudy/scalable-production-of-high-purity-nanobodies-using-yeast-expression-system/ 2025-06-16T12:31:50+00:00 https://aragen.targetedgestaging.in/wp-content/uploads/2025/03/cs-bg-image.jpg https://aragen.targetedgestaging.in/casestudy/unravelling-immunological-depths-exploring-oxazolone-induced-delayed-type-hypersensitivity-model/ 2025-06-16T12:32:33+00:00 https://aragen.targetedgestaging.in/wp-content/uploads/2024/07/DTH-banner.jpg https://aragen.targetedgestaging.in/casestudy/unlocking-insights-a-translational-mouse-model-for-non-genetic-heterotopic-ossification/ 2025-06-16T12:33:00+00:00 https://aragen.targetedgestaging.in/wp-content/uploads/2024/06/hetero_1.jpg https://aragen.targetedgestaging.in/casestudy/a-pre-clinical-study-for-diet-induced-obesity/ 2025-06-16T12:33:32+00:00 https://aragen.targetedgestaging.in/wp-content/uploads/2024/06/1_1.jpg https://aragen.targetedgestaging.in/casestudy/designing-an-optimal-and-scalable-protocol-for-formulating-a-40-emulsifiable-concentrate-for-a-systemic-insecticide/ 2025-06-16T12:34:03+00:00 https://aragen.targetedgestaging.in/wp-content/uploads/2023/12/banner_img.jpg https://aragen.targetedgestaging.in/casestudy/case-study-developing-a-thermodynamically-stable-microemulsion-with-fine-droplet-size-for-delivering-a-highly-lipophilic-drug-with-limited-intestinal-permeability/ 2025-06-16T12:35:31+00:00 https://aragen.targetedgestaging.in/wp-content/uploads/2024/01/banner_2-1.jpg https://aragen.targetedgestaging.in/casestudy/case-study-elevating-purity-levels-racemizing-pharmaceutical-products-in-advanced-flow-microreactors/ 2025-06-16T12:36:03+00:00 https://aragen.targetedgestaging.in/wp-content/uploads/2024/01/Banner_.jpg https://aragen.targetedgestaging.in/casestudy/case-study-modelling-targeted-protein-degraders-tpds-utilizing-computational-and-medicinal-chemistry-approaches/ 2025-06-16T12:36:31+00:00 https://aragen.targetedgestaging.in/wp-content/uploads/2024/01/banner_4.jpg https://aragen.targetedgestaging.in/casestudy/case-study-flow-chemistry-experiments-of-highly-hazardous-butyl-lithium-reactions/ 2025-06-16T12:37:02+00:00 https://aragen.targetedgestaging.in/wp-content/uploads/2024/01/banner_5.jpg https://aragen.targetedgestaging.in/casestudy/case-study-a-robust-and-scalable-strategy-to-develop-monodisperse-nanosuspension-formulation-for-a-poorly-soluble-drug-substancea-case-study/ 2025-06-16T12:37:25+00:00 https://aragen.targetedgestaging.in/wp-content/uploads/2024/01/banner_6.jpg https://aragen.targetedgestaging.in/casestudy/case-study-a-robust-and-scalable-strategy-to-develop-amorphous-solid-dispersion-formulation-for-a-poorly-soluble-drug-substance-a-case-study/ 2025-06-16T12:37:56+00:00 https://aragen.targetedgestaging.in/wp-content/uploads/2024/01/banner_7.jpg https://aragen.targetedgestaging.in/casestudy/case-study-expression-in-vivo-maturation-and-tag-less-purification-of-a-recombinant-protein/ 2025-06-16T12:38:20+00:00 https://aragen.targetedgestaging.in/wp-content/uploads/2024/01/banner_8.jpg https://aragen.targetedgestaging.in/casestudy/enhancing-crystallization-control-with-in-line-pat-for-scalable-manufacturing/ 2025-09-18T12:55:41+00:00 https://aragen.targetedgestaging.in/wp-content/uploads/2025/09/Banner-1-1.jpg https://aragen.targetedgestaging.in/casestudy/rsv-challenge-model-for-anti-rsv-therapy/ 2025-11-18T06:21:15+00:00 https://aragen.targetedgestaging.in/wp-content/uploads/2023/12/rsv_banner.jpg https://aragen.targetedgestaging.in/casestudy/clinically-relevant-preclinical-model-of-cfa-induced-inflammatory-pain/ 2025-11-18T06:46:32+00:00 https://aragen.targetedgestaging.in/wp-content/uploads/2024/02/cfa_banner.jpg https://aragen.targetedgestaging.in/casestudy/experimental-%ce%bb-carrageenan-induced-inflammatory-pain-model-for-testing-novel-analgesics/ 2025-11-18T06:49:35+00:00 https://aragen.targetedgestaging.in/wp-content/uploads/2023/12/artical-banner.jpg https://aragen.targetedgestaging.in/casestudy/a-comparative-efficiency-analysis-of-commercial-transfection-reagents-in-hek-293-cells/ 2025-11-18T06:56:04+00:00 https://aragen.targetedgestaging.in/wp-content/uploads/2023/12/hek_article_banner.jpg https://aragen.targetedgestaging.in/casestudy/streptozotocin-induced-diabetic-peripheral-neuropathic-pain-model-developed-at-aragen/ 2025-11-18T07:09:46+00:00 https://aragen.targetedgestaging.in/wp-content/uploads/2024/02/idp_1.jpg https://aragen.targetedgestaging.in/casestudy/pharmacokinetic-study-of-salbutamol-through-nose-only-exposure-in-cd-1-male-mice/ 2025-11-18T07:13:05+00:00 https://aragen.targetedgestaging.in/wp-content/uploads/2024/02/lung_1.jpg https://aragen.targetedgestaging.in/casestudy/aragens-bleomycin-induced-scleroderma-mouse-model-for-preclinical-testing-of-novel-therapeutics/ 2025-11-18T07:18:21+00:00 https://aragen.targetedgestaging.in/wp-content/uploads/2023/12/scleroderma_banner.jpg https://aragen.targetedgestaging.in/casestudy/an-optimal-upstream-process-development-approach-to-increase-the-titers-of-the-monoclonal-antibodies-mabs/ 2025-11-24T07:24:08+00:00 https://aragen.targetedgestaging.in/wp-content/uploads/2023/12/1.jpg https://aragen.targetedgestaging.in/casestudy/strategic-optimization-of-small-molecule-inhibitors-for-enhanced-tumor-growth-inhibition/ 2025-12-01T07:03:29+00:00 https://aragen.targetedgestaging.in/wp-content/uploads/2025/11/Banner-5-1.jpg https://aragen.targetedgestaging.in/casestudy/enhancing-palatability-in-a-dual-api-oral-formulation-for-canine-health/ 2025-12-04T05:58:22+00:00 https://aragen.targetedgestaging.in/wp-content/uploads/2025/12/Formulation.jpg https://aragen.targetedgestaging.in/casestudy/optimized-spr-based-screening-of-rna-targeting-small-molecules/ 2025-12-10T10:38:22+00:00 https://aragen.targetedgestaging.in/wp-content/uploads/2025/11/SPR-Banner.jpg https://aragen.targetedgestaging.in/casestudy/advancing-peptide-therapeutics-through-efficient-synthesis-of-unnatural-amino-acids/ 2025-12-10T10:55:22+00:00 https://aragen.targetedgestaging.in/wp-content/uploads/2025/12/Banner-5.jpg https://aragen.targetedgestaging.in/casestudy/transforming-biologics-manufacturing-through-smart-upstream-process-intensification/ 2025-12-22T05:16:36+00:00 https://aragen.targetedgestaging.in/wp-content/uploads/2025/10/Banner-2.jpg https://aragen.targetedgestaging.in/casestudy/optimizing-co-crystal-crystallization-for-robustness-and-scalability/ 2026-01-05T10:53:44+00:00 https://aragen.targetedgestaging.in/wp-content/uploads/2021/03/SM-Discovery-Development-Drug-Substance-Landing.jpg https://aragen.targetedgestaging.in/casestudy/scalable-production-of-unique-pseudoproline-and-dmb-dipeptides-for-efficient-spps/ 2026-01-22T10:59:20+00:00 https://aragen.targetedgestaging.in/wp-content/uploads/2026/01/Banner-8_compressed.jpg https://aragen.targetedgestaging.in/casestudy/higher-selectivity-and-robust-manufacturing-through-continuous-flow/ 2026-02-03T13:22:44+00:00 https://aragen.targetedgestaging.in/wp-content/uploads/2024/06/flow_chemistry_1.jpg https://aragen.targetedgestaging.in/casestudy/developing-a-reliable-bcma-expressing-cho-k1-cell-line-to-accelerate-the-discovery-of-next-generation-cancer-therapeutics/ 2026-02-18T05:38:08+00:00 https://aragen.targetedgestaging.in/wp-content/uploads/2026/02/who-we-serve.jpg https://aragen.targetedgestaging.in/casestudy/from-challenge-to-success-high-purity-membrane-protein-production-across-multiple-classes/ 2026-02-20T08:17:55+00:00 https://aragen.targetedgestaging.in/wp-content/uploads/2026/01/PROTEIN_1.jpg https://aragen.targetedgestaging.in/casestudy/a-streamlined-crystallization-strategy-to-deliver-high-purity-r-isomer/ 2026-03-05T09:32:40+00:00 https://aragen.targetedgestaging.in/wp-content/uploads/2025/11/Webinar-banner.jpg https://aragen.targetedgestaging.in/casestudy/obesity-induced-sarcopenia-translational-mouse-model-for-muscle-metabolic-therapies/ 2026-03-09T07:48:32+00:00 https://aragen.targetedgestaging.in/wp-content/uploads/2024/06/1_1.jpg https://aragen.targetedgestaging.in/casestudy/comprehensive-bioanalytical-strategy-for-adc-therapeutics/ 2026-03-18T09:18:50+00:00 https://aragen.targetedgestaging.in/wp-content/uploads/2026/03/bioanalytical-and-bioassay-banner.webp https://aragen.targetedgestaging.in/casestudy/advancing-green-peptide-synthesis-through-optimized-spps-solvent-usage/ 2026-05-08T12:47:08+00:00 https://aragen.targetedgestaging.in/wp-content/uploads/2025/11/Banner.jpg https://aragen.targetedgestaging.in/casestudy/cysteine-directed-adc-bioconjugation-with-controlled-dar-and-functional-validation/ 2026-05-08T13:55:00+00:00 https://aragen.targetedgestaging.in/wp-content/uploads/2021/02/Peptide-Conjugates-Banner.jpg https://aragen.targetedgestaging.in/casestudy/comprehensive-preclinical-development-program-for-a-covid-mrna-vaccine/ 2026-05-26T12:30:05+00:00 https://aragen.targetedgestaging.in/wp-content/uploads/2023/12/preclinical_banner1.jpg https://aragen.targetedgestaging.in/casestudy/the-incidence-of-lung-and-spleen-tumors-in-positive-control-group-of-tg-rash2-mice-sourced-from-clea-japan/ 2026-05-26T13:23:25+00:00 https://aragen.targetedgestaging.in/wp-content/uploads/2026/04/general-toxicology_banner.webp https://aragen.targetedgestaging.in/casestudy/integrating-drug-substance-and-drug-product-development-to-accelerate-clinical-timelines/ 2026-06-05T09:18:41+00:00 https://aragen.targetedgestaging.in/wp-content/uploads/2021/05/SM-Development-Drug-Product-Clinical-Formulation.jpg